Blueprint Medicines requested priority review for this application, which, if granted, could result in a six-month review process... Dec 18
CStone is a biopharmaceutical company focused on the development and commercialization of innovative immuno-oncology and precision drugs ... Oct 30
This partnership puts LCB71 in a path to development and commercialization for patients around the world... Oct 29
-Advertisements-